Allelic distribution of HLA-B*5 in HLA-B5-positive Israeli patients with Behçet's disease

Tissue Antigens. 2001 Sep;58(3):185-6. doi: 10.1034/j.1399-0039.2001.580307.x.

Abstract

In order to investigate the sub-typing of the B5 antigen in Israeli (Jewish and Arabic) patients with Behçet's disease (BD) allele-specific genotyping of B51 and B52 alleles was performed in Israeli BD patients and healthy controls. Among the HLA-B51-positive BD patients, B*5101 was found to be the predominant allele, identified in 62% of all BD patients and 78% of Jewish BD patients. HLA-B*5101 was also the predominant allele in HLA-B51-positive healthy controls. HLA-B*5108 and B*5104 alleles were identified in 23% and 15% of B51-positive BD patients, respectively. The HLA-B*5201 allele was identified in all HLA-B52-positive patients and controls. Our study suggests that both HLA-B*5101 and HLA-B*5201 are the dominant alleles of HLA-B5 in Israeli BD patients.

Publication types

  • Comparative Study

MeSH terms

  • Alleles
  • Behcet Syndrome / genetics*
  • Gene Frequency*
  • Genes, MHC Class I
  • Genotype
  • HLA-B Antigens / genetics*
  • HLA-B51 Antigen
  • HLA-B52 Antigen
  • Humans
  • Israel

Substances

  • HLA-B Antigens
  • HLA-B51 Antigen
  • HLA-B52 Antigen